Renhe Pharmacy (000650.SZ) controlling shareholder intends to reduce its holdings by up to 3 million shares.
Renhe Pharmaceutical (000650.SZ) announced that its controlling shareholder Renhe (Group) Development Co., Ltd. is undergoing...
Renhe Pharmacy (000650.SZ) announced that the company's controlling shareholder, Renhe (Group) Development Co., Ltd., is planning to reduce its holdings of the company's shares by no more than 3 million shares through centralized bidding or block trading within 3 months after the disclosure date of the announcement, with a reduction ratio not exceeding 0.2143% of the total shares of the company, due to its own development needs.
Related Articles

Zhaobangji Life (01660) intends to acquire 100% of the shares of Donghui Securities.

AMUSE GROUP (08545) announced its interim results, with a net profit of HKD 1.16 million, a decrease of 24.48% compared to the same period last year.

Shareholders Cloud Eagle Capital and Zheng Zixian of Zhong Zhu Healthcare Holding (600568.SH) plan to collectively transfer 10.38% of the company's shares.
Zhaobangji Life (01660) intends to acquire 100% of the shares of Donghui Securities.

AMUSE GROUP (08545) announced its interim results, with a net profit of HKD 1.16 million, a decrease of 24.48% compared to the same period last year.

Shareholders Cloud Eagle Capital and Zheng Zixian of Zhong Zhu Healthcare Holding (600568.SH) plan to collectively transfer 10.38% of the company's shares.

RECOMMEND

Energy Storage Industry Set To Ride the AI Tailwind; UBS: Global Demand May Surge 40% Next Year
13/11/2025

Double Eleven’s Cooling To A Historic Low? A Necessary Step Toward E‑commerce Maturity
13/11/2025

On The Eve of L3 Mass Commercialization: How Autonomous Driving Will Reconfigure a Trillion‑Yuan Service Market
13/11/2025


